Dermata Therapeutics, Inc (DRMA) Misses Q3 EPS by 165c
Tweet
Share
E-mailGet Alerts DRMA Hot Sheet
Join SI Premium – FREE
Dermata Therapeutics, Inc (NASDAQ: DRMA) reported Q3 EPS of ($1.65).
For earnings history and earnings-related data on Dermata Therapeutics, Inc (DRMA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Societe Generale SA (GLE:FP) (SCGLY) to Neutral
- Morgan Stanley Starts ARCHION Corp (543A:JP) at Equalweight
- Gerdes Energy Research Downgrades Cenovus Energy Inc. (CVE) to Neutral
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
